Therapy

Tartrid D

This medication combines Domperidone SR (30mg) and Esomeprazole EC (40mg) to address gastrointestinal conditions effectively. Domperidone SR, a sustained-release prokinetic agent, enhances the movement of food through the stomach and intestines, relieving symptoms like nausea, vomiting, and bloating. Esomeprazole EC, an enteric-coated proton pump inhibitor, reduces stomach acid production, providing relief from conditions such as acid reflux, GERD, and peptic ulcers. The enteric coating ensures that Esomeprazole is released in the intestine, improving its efficacy and minimizing irritation to the stomach. Together, this combination provides comprehensive relief for individuals experiencing acid-related disorders and delayed gastric emptying. It is generally taken before meals as prescribed by a healthcare professional.